In conclusion, resolution initiated via activation of the ALX/FPR2 with AT-RvD1 has a significant impact in controlling tissue homeostasis, thus preventing acute inflammation from progressing to chronic autoimmunity. The gene discussed is FPR2; the disease is Autoimmunity.